| Year |
Citation |
Score |
| 2024 |
Adam DP, Grudzinski JJ, Marsh IR, Hill PM, Cho SY, Bradshaw TJ, Longcor J, Burr A, Bruce JY, Harari PM, Bednarz BP. Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 38367914 DOI: 10.1016/j.ijrobp.2024.02.005 |
0.34 |
|
| 2023 |
Marsh IR, Li C, Grudzinski J, Jeffery J, Longhurst C, Adam DP, Hernandez R, Weichert JP, Harari PM, Bednarz BP. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry. Cancer Biotherapy & Radiopharmaceuticals. PMID 37022739 DOI: 10.1089/cbr.2022.0084 |
0.317 |
|
| 2023 |
Kostecki KL, Iida M, Wiley AL, Kimani S, Mehall B, Tetreault K, Alexandridis R, Yu M, Hong S, Salgia R, Bruce JY, Birge RB, Harari PM, Wheeler DL. Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer. Head & Neck. PMID 36939040 DOI: 10.1002/hed.27340 |
0.313 |
|
| 2023 |
Merfeld EC, Witek ME, Francis DM, Burr AR, Wallace CR, Kuczmarska-Haas A, Lamichhane N, Kimple RJ, Glazer TA, Wieland AM, McCulloch TM, Hartig GK, Harari PM. Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes. Practical Radiation Oncology. PMID 36709044 DOI: 10.1016/j.prro.2023.01.004 |
0.316 |
|
| 2022 |
Burr A, Harari P, Wieland A, Kimple R, Hartig G, Witek M. Patterns of failure for hypopharynx cancer patients treated with limited high-dose radiotherapy treatment volumes. Radiation Oncology Journal. 40: 225-231. PMID 36456541 DOI: 10.3857/roj.2022.00311 |
0.325 |
|
| 2021 |
Garden AS, Harris J, Eisbruch A, Chao KSC, Morrison WH, Harari PM, Swanson TA, Jones CU, Yom SS, Spencer SA, Scrimger RA, Shenouda G, Shukla ME, Lau H, Mierzwa ML, et al. Final Report of NRG Oncology RTOG 0022: A Phase I/II Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. International Journal of Radiation Oncology, Biology, Physics. 111: S143. PMID 34700487 DOI: 10.1016/j.ijrobp.2021.07.322 |
0.3 |
|
| 2020 |
Burr AR, Harari PM, Haasl AM, Wieland AM, Bruce JY, Kimple RJ, Hartig GK, McCulloch TM, Witek ME. Clinical outcomes for larynx patients with cancer treated with refinement of high-dose radiation treatment volumes. Head & Neck. PMID 32057151 DOI: 10.1002/Hed.26098 |
0.311 |
|
| 2020 |
Burr A, Harari P, Griffith A, Kimple R, Witek M. Treatment Outcomes for Advanced Stage Hypopharyngeal Cancer Treated without a GTV to CTV Expansion International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.574 |
0.34 |
|
| 2020 |
Burr A, Harari P, Griffith A, Haasl A, Kimple R, Glazer T, Hartig G, McCulloch T, Witek M. Clinical Outcomes for Larynx Cancer Patients Treated with Refinement of High-Dose Radiation Treatment Volumes International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.567 |
0.391 |
|
| 2020 |
Witek M, Harari P, Burr A, Chandereng T, Bruce J, Kimple R, Avey G. Intra-Treatment PET/MRI Separates Intermediate Risk p16-Positive Oropharynx Cancer Patients into Favorable and Unfavorable Cohorts International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.562 |
0.325 |
|
| 2019 |
SenthilKumar G, Miller M, Fisher M, Brennan S, Kaushik S, Able L, Harari PM, Iyer G, Kimple RJ, Baschnagel AM. Abstract 2929: Radiosensitization of head and neck cancer by FGFR inhibition Cancer Research. 79: 2929-2929. DOI: 10.1158/1538-7445.Am2019-2929 |
0.338 |
|
| 2018 |
Elsaid MY, Shahi A, Wang AR, Baiu DC, Li C, Werner LR, Singhal S, Hall LT, Weichert JP, Armstrong EA, Bednarz BP, Harari PM, Iyer G, Otto M. Enhanced Radiosensitivity in Solid Tumors using a Tumor-Selective Alkyl Phosphocholine Analog. Molecular Cancer Therapeutics. PMID 30108133 DOI: 10.1158/1535-7163.Mct-17-0897 |
0.325 |
|
| 2018 |
Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, ... ... Harari PM, et al. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. The Lancet. Oncology. 19: e240-e251. PMID 29726389 DOI: 10.1016/S1470-2045(18)30096-2 |
0.302 |
|
| 2018 |
Li C, Mylin JM, Weichert JP, Jeffery JJ, Weichmann AM, Nickel KP, Abel LJ, Hernandez R, Grudzinski JJ, Marsh IR, Bednarz BP, Piaskowski SM, Harari PM. Abstract 851: Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer murine xenograft models Cancer Research. 78: 851-851. DOI: 10.1158/1538-7445.Am2018-851 |
0.353 |
|
| 2018 |
Abbariki M, Toulany M, Iida M, Morgan A, Nickel K, McDaniel N, Kang G, Li C, Harari P, Wheeler D. Abstract 846: Co-targeting of Axl and MerTK improves radiation response in HNSCC Cancer Research. 78: 846-846. DOI: 10.1158/1538-7445.Am2018-846 |
0.413 |
|
| 2017 |
Prabakaran PJ, Javaid AM, Swick AD, Werner LR, Nickel KP, Sampene E, Hu R, Ong IM, Bruce JY, Hartig GK, Wieland A, Canon J, Harari PM, Kimple RJ. Radiosensitization of adenoid cystic carcinoma with MDM2 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28659312 DOI: 10.1158/1078-0432.Ccr-17-0969 |
0.323 |
|
| 2017 |
Javaid A, Swick AD, Werner L, Prabakaran P, Hu R, Nickel KP, Ong I, Sampene E, Bruce J, Hartig G, Wieland A, Canon J, Harari P, Kimple R. Abstract 5187: Potent radiosensitization of adenoid cystic carcinoma in a patient derived xenograft model using the MDM2 inhibitor AMG 232 Cancer Research. 77: 5187-5187. DOI: 10.1158/1538-7445.Am2017-5187 |
0.303 |
|
| 2017 |
Musunuru H, Rosenberg S, Bayouth J, Mitteur K, Ritter M, Paliwal B, Witek M, Baschnagel A, Uboha N, Lubner S, Loconte N, Harari P, Bassetti M. PV-0322: Rapid Early Response of Gastroesophageal Junction Tumors During Real-time MRI-Guided Radiotherapy Radiotherapy and Oncology. 123: S168-S169. DOI: 10.1016/S0167-8140(17)30764-8 |
0.304 |
|
| 2017 |
Ko HC, Chen S, Wieland A, Yu M, Baschnagel A, Brower J, McCulloch T, Hartig G, Harari P, Witek M. OC-006: Outcomes of head and neck cancer with N3 nodal disease: a review of the National Cancer Data Base Radiotherapy and Oncology. 122: 6-7. DOI: 10.1016/S0167-8140(17)30163-9 |
0.364 |
|
| 2017 |
Musunuru H, Yadav P, Ko H, Kennedy T, Harari P, Witek M. Can Elective Neck Radiation Treatment Volumes be Safely Reduced to Diminish Toxicity Profiles for Oropharynx Cancer Patients? International Journal of Radiation Oncology*Biology*Physics. 99: E361. DOI: 10.1016/j.ijrobp.2017.06.1464 |
0.321 |
|
| 2016 |
Mittauer K, Rosenberg S, Geurts M, Bassetti M, Chen I, Henke L, Olsen J, Kashani R, Wojcieszynski A, Harari P, Labby Z, Hill P, Paliwal B, Parikh P, Bayouth J. TU-AB-BRA-11: Indications for Online Adaptive Radiotherapy Based On Dosimetric Consequences of Interfractional Pancreas-To-Duodenum Motion in MRI-Guided Pancreatic Radiotherapy. Medical Physics. 43: 3735-3736. PMID 28047289 DOI: 10.1118/1.4957421 |
0.313 |
|
| 2016 |
Bonner J, Giralt J, Harari P, Spencer S, Schulten J, Hossain A, Chang SC, Chin S, Baselga J. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial. Jama Otolaryngology-- Head & Neck Surgery. PMID 27389475 DOI: 10.1001/Jamaoto.2016.1228 |
0.346 |
|
| 2016 |
Prabakaran P, Nickel KP, Yang DT, Werner LR, Bruce JY, Wieland AM, McCulloch TM, Hartig GK, Harari PM, Swick AD, Kimple RJ. Abstract 3044: Patient-derived adenoid cystic carcinoma xenografts to study molecular target modulation of tumor radiosensitivity Cancer Research. 76: 3044-3044. DOI: 10.1158/1538-7445.Am2016-3044 |
0.328 |
|
| 2016 |
Mittauer K, Geurts M, Toya R, Bassetti M, Harari P, Paliwal B, Bayouth J. TH-CD-202-11: Implications for Online Adaptive and Non-Adaptive Radiotherapy of Gastic and Gastroesophageal Junction Cancers Using MRI-Guided Radiotherapy Medical Physics. 43: 3879-3879. DOI: 10.1118/1.4958168 |
0.312 |
|
| 2015 |
Li C, Huang S, Armstrong EA, Francis DM, Werner LR, Sliwkowski MX, Kogel AV, Harari PM. Antitumor effects of MEHD7945A, a dual specific antibody against EGFR and HER3, in combination with radiation in lung and head and neck cancers. Molecular Cancer Therapeutics. PMID 26141946 DOI: 10.1158/1535-7163.MCT-15-0155 |
0.334 |
|
| 2015 |
Morris ZS, Weichert JP, Saker J, Armstrong EA, Besemer A, Bednarz B, Kimple RJ, Harari PM. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 504-9. PMID 26123834 DOI: 10.1016/J.Radonc.2015.06.015 |
0.323 |
|
| 2015 |
Schwartz DL, Harris J, Yao M, Rosenthal DI, Opanowski A, Levering A, Ang KK, Trotti AM, Garden AS, Jones CU, Harari P, Foote R, Holland J, Zhang Q, Le QT. Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522. International Journal of Radiation Oncology, Biology, Physics. 91: 721-9. PMID 25752384 DOI: 10.1016/J.Ijrobp.2014.12.023 |
0.409 |
|
| 2015 |
Nyflot MJ, Kruser TJ, Traynor AM, Khuntia D, Yang DT, Hartig GK, McCulloch TM, Wiederholt PA, Gentry LR, Hoang T, Jeraj R, Harari PM. Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion. International Journal of Radiation Oncology, Biology, Physics. 91: 942-51. PMID 25659884 DOI: 10.1016/J.Ijrobp.2014.11.029 |
0.323 |
|
| 2014 |
Cannon DM, Geye HM, Hartig GK, Traynor AM, Hoang T, McCulloch TM, Wiederholt PA, Chappell RJ, Harari PM. Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head & Neck. 36: 1120-5. PMID 23804248 DOI: 10.1002/Hed.23419 |
0.341 |
|
| 2014 |
Magnuson WJ, Morris Z, Mohindra P, Geye H, Harari P. Potential Influence of ACE Inhibitors and Angiotensin Receptor Blockers on Outcome in Patients With Oropharynx Cancer Treated With Radiation Therapy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1581 |
0.378 |
|
| 2013 |
Huang S, Peet CR, Saker J, Li C, Armstrong EA, Kragh M, Pedersen MW, Harari PM. Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers. Molecular Cancer Therapeutics. 12: 2772-81. PMID 24130052 DOI: 10.1158/1535-7163.Mct-13-0587 |
0.319 |
|
| 2013 |
Saker J, Armstrong E, Bednarz B, Farhoud M, Besemer A, Weichert J, Harari P. Abstract 4536: Combination external beam and internal radiation via 131I-CLR1404 in the treatment of head and neck squamous cell carcinoma xenografts. Cancer Research. 73: 4536-4536. DOI: 10.1158/1538-7445.Am2013-4536 |
0.447 |
|
| 2013 |
Saker J, Huang S, Park L, Pedersen M, Kragh M, Harari P. Abstract 1027: EGFR targeting antibody SYM004 causes radiosensitization in tumor cells expressing wild-type K-Ras via modulation of MAPK signaling. Cancer Research. 73: 1027-1027. DOI: 10.1158/1538-7445.Am2013-1027 |
0.4 |
|
| 2013 |
Mohindra P, Barasch S, Yang D, Patel V, Khuntia D, Hoang T, Speer T, McCulloch T, Hartig G, Harari P. PO-125: Primary Radiation-Based Management of Oropharyngeal Cancer: A Comprehensive 20-Year Single Institution Review Radiotherapy and Oncology. 106. DOI: 10.1016/S0167-8140(15)34744-7 |
0.335 |
|
| 2013 |
Schwartz D, Harris J, Yao M, Trotti A, Garden A, Jones C, Harari P, Foote R, Holland J, Ang K. Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head-and-Neck Cancer: Pilot Results From RTOG 0522 International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.496 |
0.374 |
|
| 2012 |
Speer TW, Bernhardt P, Bednarz B, Harari P, Saker J, Thomadsen B. Feasibility of the Systemic Cure of Cancer With Targeted Radionuclide Therapy (TRT) International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1898 |
0.313 |
|
| 2011 |
Harari PM, Khuntia D, Traynor AM, Hoang T, Yang DT, Hartig GK, McCulloch TM, Jeraj R, Nyflot MJ, Wiederholt PA, Gentry LR. Phase I trial of bevacizumab combined with concurrent chemoradiation for squamous cell carcinoma of the head and neck: Preliminary outcome results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5518. PMID 28021430 DOI: 10.1200/Jco.2011.29.15_Suppl.5518 |
0.305 |
|
| 2011 |
Wong SJ, Harari PM, Garden AS, Schwartz M, Bellm L, Chen A, Curran WJ, Murphy BA, Ang KK. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States. Cancer. 117: 1679-86. PMID 21472715 DOI: 10.1002/cncr.25721 |
0.324 |
|
| 2011 |
Nyflot M, Simoncic U, Harari P, Perlman S, Jeraj R. SU-D-BRC-06: Multimodality Assessment of Response to Combined Chemoradiation and Anti-Angiogenic Therapy with CuATSM-PET, FLT-PET, and Contrast-Enhanced CT Imaging Medical Physics. 38: 3385-3385. DOI: 10.1118/1.3611530 |
0.325 |
|
| 2011 |
Bavan B, Krakow T, Pinto H, Harari P, Brizel D, Amdur R, Hu KW, Le Q. Interim Report of a Phase II Study of Lapatinib and Concurrent Radiotherapy in Patients With Locally Advanced Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.831 |
0.377 |
|
| 2010 |
Traynor AM, Richards GM, Hartig GK, Khuntia D, Cleary JF, Wiederholt PA, Bentzen SM, Harari PM. Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience. Head & Neck. 32: 599-606. PMID 19757422 DOI: 10.1002/Hed.21224 |
0.325 |
|
| 2010 |
Song C, Nyflot M, Harari P, Perlman S, Jeraj R. MO-D-204B-08: Classification and Characterization of Tumor Subpopulations Using Molecular Imaging Medical Physics. 37: 3343-3343. DOI: 10.1118/1.3469069 |
0.319 |
|
| 2010 |
Nyflot M, Harari P, Perlman S, Jeraj R. MO-D-204B-03: Correlation of PET Images of Metabolism, Proliferation and Hypoxia to Characterize Tumor Phenotype in Patients with HNSCC Medical Physics. 37: 3342-3342. DOI: 10.1118/1.3469064 |
0.342 |
|
| 2009 |
Hatakeyama H, Parker J, Wheeler D, Harari P, Levy S, Chung CH. Effect of insulin-like growth factor 1 receptor inhibitor on sensitization of head and neck cancer cells to cetuximab and methotrexate. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6079. PMID 27961955 DOI: 10.1200/Jco.2009.27.15_Suppl.6079 |
0.368 |
|
| 2009 |
Curran WJ, Chen AY, Garden AS, Harari P, Murphy BA, Wong S, Bellm LA, Schwartz M, Dawson D, Ang KK. Longitudinal oncology registry of head and neck carcinoma (LORHAN): First report of outcomes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6071. PMID 27961937 DOI: 10.1200/Jco.2009.27.15_Suppl.6071 |
0.344 |
|
| 2009 |
Nyflot M, Harari P, Perlman S, Nickles R, Jeraj R. SU-FF-J-135: Quantification of Tumor Proliferation and Hypoxia with PET/CT Imaging of HNSCC Patients Receiving VEGF-Targeted Therapy Medical Physics. 36: 2507-2508. DOI: 10.1118/1.3181427 |
0.382 |
|
| 2008 |
Curran WJ, Chen A, Garden A, Harari P, Murphy BA, Wong SJ, Bellm L, Schwartz M, Dawson D, Ang K. Longitudinal oncology registry of head and neck carcinoma (LORHAN): Initial treatment findings. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 6054. PMID 27950599 DOI: 10.1200/Jco.2008.26.15_Suppl.6054 |
0.392 |
|
| 2008 |
Been MJ, Watkins J, Manz RM, Gentry LR, Leverson GE, Harari PM, Hartig GK. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy. The Laryngoscope. 118: 1377-82. PMID 18418275 DOI: 10.1097/MLG.0b013e318172c82c |
0.328 |
|
| 2008 |
Bentzen SM, Harari PM, Tomé WA, Mehta MP. Radiation oncology advances: an introduction. Cancer Treatment and Research. 139: 1-4. PMID 18236709 DOI: 10.1007/978-0-387-36744-6_1 |
0.302 |
|
| 2008 |
Nyflot M, Grudzinski J, Titz B, Armstrong E, Wheeler D, Harari P, Jeraj R. TH-C-351-04: 18F-FLT PET Imaging of Proliferative Response to An EGFR Inhibitor in HNSCC Xenograft Mouse Models Medical Physics. 35: 2975-2975. DOI: 10.1118/1.2962860 |
0.367 |
|
| 2008 |
Jeraj R, Simoncic U, McCall K, Harari P, Mehta M, Nickles R, Perlman S. MO-E-AUD C-03: Use of FLT-PET Imaging to Assess Tumor and Normal Tissue Response to Radiotherapy Medical Physics. 35: 2876-2876. DOI: 10.1118/1.2962392 |
0.363 |
|
| 2008 |
Sonis ST, Jacquin P, Randolph-Jackson P, Harari P, Grunberg S, Liao Z, Bolek T, Elting L, Keefe D. Prevalence of Mouth and Throat Soreness (MTS) in Patients undergoing Lung Cancer Treatment, with Adverse Impact on Functional and Quality of Life Outcomes International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.395 |
0.305 |
|
| 2008 |
Keefe DM, Elting LS, Sonis ST, Garden A, Spijkervet F, Barasch A, Jacquin P, Randolph P, Harari P. Treatment for Head and Neck Cancer and for Lung Cancer Causes Significant Diarrhea International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1432 |
0.365 |
|
| 2008 |
Garden A, Chen A, Curran W, Harari P, Murphy B, Wong S, Schwartz M, Dawson D, Dempsey C, Ang K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Preliminary Report Regarding Radiation Patterns of Care International Journal of Radiation Oncology*Biology*Physics. 72: S409-S410. DOI: 10.1016/J.Ijrobp.2008.06.1305 |
0.356 |
|
| 2007 |
Harari PM. Stepwise progress in epidermal growth factor receptor/radiation studies for head and neck cancer. International Journal of Radiation Oncology, Biology, Physics. 69: S25-7. PMID 17848286 DOI: 10.1016/j.ijrobp.2007.04.087 |
0.316 |
|
| 2007 |
Jeraj R, McCall K, Bentzen S, Harari P, Ritter M, Mehta M, Tome W. TH-E-M100J-05: Early Assessment of Radiotherapy Efficacy with FLT-PET Imaging Medical Physics. 34: 2650-2650. DOI: 10.1118/1.2761758 |
0.377 |
|
| 2007 |
Murphy B, Chen A, Harari P, Curran W, Wong S, Bellm L, Gamber D, Dawson D, Garden A, Ang K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), A New National Cancer Registry International Journal of Radiation Oncology*Biology*Physics. 69: S138-S139. DOI: 10.1016/J.Ijrobp.2007.06.008 |
0.394 |
|
| 2007 |
Bonner J, Harari P, Giralt J, Raben D, Jassem J, Azarnia N, Spencer S, Rowinsky E, Amellal N, Baselga J, Ang K. Duration of Mucositis and Dysphagia following Radiotherapy (+ Cetuximab) for Locoregionally Advanced Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 69: S137. DOI: 10.1016/J.IJROBP.2007.06.005 |
0.316 |
|
| 2006 |
Astsaturov I, Cohen RB, Harari P. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer Expert Review of Anticancer Therapy. 6: 1179-1193. PMID 17020453 DOI: 10.1586/14737140.6.9.1179 |
0.402 |
|
| 2006 |
Curran W, Chen A, Harari P, Murphy B, Wong S, Bellm L, Gamber D, Dawson D, Ang K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry Journal of Clinical Oncology. 24: 5583-5583. DOI: 10.1200/Jco.2006.24.18_Suppl.5583 |
0.378 |
|
| 2005 |
Bonner JA, Harari PM, Giralt J, Baselga J, Shin D, Cohen R, Jassem J, Azarnia N, Molloy P, Ang KK. Improved preservation of larynx with the addition of cetuximab to radiation for cancers of the larynx and hypopharynx. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5533. PMID 27945270 DOI: 10.1200/jco.2005.23.16_suppl.5533 |
0.309 |
|
| 2005 |
Harari PM. Promising new advances in head and neck radiotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. vi13-vi19. PMID 15987991 DOI: 10.1093/ANNONC/MDI453 |
0.339 |
|
| 2005 |
Hong TS, Tomé WA, Harari PM. Intensity-modulated radiation therapy in the management of head and neck cancer. Current Opinion in Oncology. 17: 231-5. PMID 15818166 DOI: 10.1097/01.Cco.0000158734.84099.38 |
0.321 |
|
| 2005 |
Benavente S, Huang S, Armstrong E, Harari P. P-938 Profiling radiation response in EGFR inhibitor-resistant human tumor cells Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)81431-X |
0.347 |
|
| 2005 |
Allen G, Modhia F, Armstrong E, Huang S, Harari P. Insulin-Like Growth Factor-1 Receptor Signaling Blockade Modulates Cellular Proliferation, Angiogenesis, Xenograft Growth and Radiation-Induced Apoptosis International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.200 |
0.346 |
|
| 2004 |
Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang S, Harari P. Modulating radiation response with the histone deacetylase (HDAC) inhibitor SAHA in human carcinomas International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.178 |
0.308 |
|
| 2003 |
Harari PM, Mehta MP, Ritter MA, Petereit DG. Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors. Seminars in Radiation Oncology. 13: 3-12. PMID 12520459 DOI: 10.1053/SRAO.2003.50001 |
0.305 |
|
| 2002 |
Raben D, Bianco C, Helfrich B, Weng E, Ciardiello F, Harari P. Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment Expert Review of Anticancer Therapy. 2: 461-471. PMID 12647989 DOI: 10.1586/14737140.2.4.461 |
0.429 |
|
| 2001 |
Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. International Journal of Radiation Oncology, Biology, Physics. 49: 427-33. PMID 11173137 DOI: 10.1016/S0360-3016(00)01488-7 |
0.33 |
|
| 2000 |
Huang S, Li J, Waksal H, Harari P. Molecular blockade of the EGF receptor combined with radiation in the treatment of head and neck cancer patients: Bench-to-bedside development International Journal of Radiation Oncology*Biology*Physics. 48: 262-263. DOI: 10.1016/S0360-3016(00)80323-5 |
0.313 |
|
| 1998 |
Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head & Neck. 20: 132-7. PMID 9484944 DOI: 10.1002/(SICI)1097-0347(199803)20:2<132::AID-HED6>3.0.CO;2-3 |
0.318 |
|
| 1995 |
Harari PM, Kinsella TJ. Advances in radiation therapy for head and neck cancer. Current Opinion in Oncology. 7: 248-54. PMID 7654827 DOI: 10.1097/00001622-199505000-00010 |
0.348 |
|
| 1994 |
McGinn CJ, Harari PM, Fowler JF, Gould PM, Kinsella TJ. Locoregional tumor control in head and neck (H&N) cancer patients following hyperfractionated, accelerated radiotherapy with dose escalation (HARDE) International Journal of Radiation Oncology*Biology*Physics. 30: 260-261. DOI: 10.1016/0360-3016(94)90810-9 |
0.302 |
|
| 1993 |
McGinn CJ, Harari PM, Fowler JF, Ford CN, Pyle GM, Kinsella TJ. Dose intensification in curative head and neck cancer radiotherapy-Linear quadratic analysis and preliminary assessment of clinical results International Journal of Radiation Oncology, Biology, Physics. 27: 363-369. PMID 8407411 DOI: 10.1016/0360-3016(93)90248-T |
0.33 |
|
| 1992 |
Harari PM, Fowler JF. Fractionation in radiation therapy — part I — clinical emphasis, head and neck cancer International Journal of Radiation Oncology*Biology*Physics. 24: 106. DOI: 10.1016/0360-3016(92)90107-S |
0.308 |
|
| Show low-probability matches. |